 The prognosis of CRC depends to a great extent on its stage when diagnosed. Patients with advanced disease, who present up to 40 of all patients, have a poor prognosis. Although the application of modern chemotherapy and radiotherapy treatments obtains median survival periods of around 24 months, the proportion of patients with advanced disease who obtain a cure is low. 